The global anti-acne drugs market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Rise in androgen (estrogen, in women) levels during puberty trigger the onset of this condition by enlarging oil glands under the skin. Several factors such as smoking, hormonal changes, and excessive secretion of sebum, among others result in a growing prevalence of acne. Anti-acne drugs work by targeting the reduction of sebum secretion and eliminating the bacteria. Acne is categorized into two types, namely inflammatory and non-inflammatory acne. The major factors that are expected to boost the market include the rising prevalence of acne ailments globally. A sedentary lifestyle and increasing acceptance of skincare solutions are some other factors that are expected to accelerate the growth of the market. Availability and emergence of effective drugs constituting antibiotic agents and complimentary benefits relating to their use would increase the demand for anti-acne drugs. 

Several factors such as smoking, hormonal changes, and excessive secretion of sebum, among others have resulted in a growing prevalence of acne. The disease burden of acne supports the demand for acne drugs across the globe. Some key players operating in the market include Johnson & Johnson Services, Inc., Galderma S.A., and Allergan plc, among others. The market players are eyeing on strengthening their position in the market by adopting various strategies such as mergers and acquisitions, partnerships, collaborations, new product launch and development in the existing product portfolio, and so on. For instance, in September 2019, B&B Labs, one of the leading Asian cosmeceutical companies, has introduced its latest plant-based anti-acne product line, which combines cutting-edge pharma-derma research with Asia's vast array of plant and herbal extracts.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By Mode of Administration
• By Distribution Channel 

Regions covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape:  Johnson & Johnson Services, Inc., Galderma S.A., and Allergan plc, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anti-Acne Drugs Market Report by Segment

By Type

• Accutane
• Benzamycin
• Cleocin T
• Desquam-E
• Erythromycin Topical
• Minocin
• Retin-A

By Mode of Administration

• Oral
• Injectable
• Topical

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Anti-Acne Drugs Market Report by Region

North America       

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific    

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa